Beone Medicines Ltd. Class A · SSE:688235
Baker Bros. Advisors LP reported a 7.80% stake in Beone Medicines Ltd. Class A (Schedule 13D/A)
Event Sep 14, 2026 · Filed Sep 16, 2026
Baker Bros. Advisors LP reported a 7.80% stake in Beone Medicines Ltd. Class A, 115,457,154 shares, with active intent on Sep 14, 2026. Filed Sep 16, 2026 (Schedule 13D/A).
- Stake
- 7.80%
- Shares
- 115,457,154
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Baker Bros. Advisors LP | 7.80% | 115,457,154 |
| Baker Bros. Advisors (GP) LLC | 7.80% | 115,457,154 |
| Julian C. Baker | 7.80% | 115,912,814 |
| Felix J. Baker | 7.80% | 115,912,814 |
| FBB3 LLC | 0.01% | 144,517 |
Source
Related
- Beone Medicines Ltd. Class A
- Baker Bros. Advisors LP
- Beone Medicines Ltd. Class A shareholders
- Schedule 13D/A · Baker Bros. Advisors LP · Jun 15, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Apr 16, 2026
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Form 4 · Wang Xiaodong · Sep 10, 2026